<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Regeneron Pharmaceuticals, Inc. - Common Stock</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">

        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="../GameResult.html">Back</a>
            <h1>Regeneron Pharmaceuticals, Inc. - Common Stock</h1>
            <img src="REGN.png" class="img-fluid">
            
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Listing</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>07-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>2</td>
                        <td>$479.87</td>
                        <td>$959.75</td>
                    </tr>
                    <tr scope="row">
                        <td>08-01-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-2</td>
                        <td>$497.36</td>
                        <td>-$994.71</td>
                    </tr>
                    <tr scope="row">
                        <td>22-02-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>12</td>
                        <td>$459.31</td>
                        <td>$5,511.72</td>
                    </tr>
                    <tr scope="row">
                        <td>23-02-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-12</td>
                        <td>$466.74</td>
                        <td>-$5,600.88</td>
                    </tr>
                    <tr scope="row">
                        <td>16-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>22</td>
                        <td>$480.84</td>
                        <td>$10,578.50</td>
                    </tr>
                    <tr scope="row">
                        <td>17-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-22</td>
                        <td>$494.64</td>
                        <td>-$10,882.14</td>
                    </tr>
                    <tr scope="row">
                        <td>25-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>28</td>
                        <td>$462.20</td>
                        <td>$12,941.67</td>
                    </tr>
                    <tr scope="row">
                        <td>26-03-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-28</td>
                        <td>$475.60</td>
                        <td>-$13,316.67</td>
                    </tr>
                    <tr scope="row">
                        <td>15-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>43</td>
                        <td>$493.28</td>
                        <td>$21,210.89</td>
                    </tr>
                    <tr scope="row">
                        <td>16-04-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-43</td>
                        <td>$501.21</td>
                        <td>-$21,552.22</td>
                    </tr>
                    <tr scope="row">
                        <td>11-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>79</td>
                        <td>$499.81</td>
                        <td>$39,484.86</td>
                    </tr>
                    <tr scope="row">
                        <td>12-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-79</td>
                        <td>$505.74</td>
                        <td>-$39,953.62</td>
                    </tr>
                    <tr scope="row">
                        <td>12-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>79</td>
                        <td>$505.74</td>
                        <td>$39,953.62</td>
                    </tr>
                    <tr scope="row">
                        <td>13-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-79</td>
                        <td>$515.74</td>
                        <td>-$40,743.80</td>
                    </tr>
                    <tr scope="row">
                        <td>27-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>108</td>
                        <td>$493.97</td>
                        <td>$53,349.25</td>
                    </tr>
                    <tr scope="row">
                        <td>28-05-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-108</td>
                        <td>$501.04</td>
                        <td>-$54,112.85</td>
                    </tr>
                    <tr scope="row">
                        <td>23-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>186</td>
                        <td>$528.34</td>
                        <td>$98,271.15</td>
                    </tr>
                    <tr scope="row">
                        <td>24-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-186</td>
                        <td>$542.95</td>
                        <td>-$100,988.54</td>
                    </tr>
                    <tr scope="row">
                        <td>29-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>200</td>
                        <td>$544.47</td>
                        <td>$108,894.97</td>
                    </tr>
                    <tr scope="row">
                        <td>30-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-200</td>
                        <td>$557.00</td>
                        <td>-$111,400.05</td>
                    </tr>
                    <tr scope="row">
                        <td>30-06-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>200</td>
                        <td>$557.00</td>
                        <td>$111,400.05</td>
                    </tr>
                    <tr scope="row">
                        <td>01-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-200</td>
                        <td>$573.04</td>
                        <td>-$114,607.19</td>
                    </tr>
                    <tr scope="row">
                        <td>01-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>200</td>
                        <td>$573.04</td>
                        <td>$114,607.19</td>
                    </tr>
                    <tr scope="row">
                        <td>02-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-200</td>
                        <td>$582.03</td>
                        <td>-$116,406.23</td>
                    </tr>
                    <tr scope="row">
                        <td>14-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>221</td>
                        <td>$579.46</td>
                        <td>$128,060.26</td>
                    </tr>
                    <tr scope="row">
                        <td>15-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-221</td>
                        <td>$587.70</td>
                        <td>-$129,880.69</td>
                    </tr>
                    <tr scope="row">
                        <td>02-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>311</td>
                        <td>$575.54</td>
                        <td>$178,992.63</td>
                    </tr>
                    <tr scope="row">
                        <td>03-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-311</td>
                        <td>$584.89</td>
                        <td>-$181,901.78</td>
                    </tr>
                    <tr scope="row">
                        <td>04-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>321</td>
                        <td>$579.35</td>
                        <td>$185,970.87</td>
                    </tr>
                    <tr scope="row">
                        <td>05-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-321</td>
                        <td>$600.81</td>
                        <td>-$192,859.75</td>
                    </tr>
                    <tr scope="row">
                        <td>12-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>361</td>
                        <td>$606.32</td>
                        <td>$218,882.93</td>
                    </tr>
                    <tr scope="row">
                        <td>13-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-361</td>
                        <td>$623.07</td>
                        <td>-$224,927.41</td>
                    </tr>
                    <tr scope="row">
                        <td>16-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>359</td>
                        <td>$626.87</td>
                        <td>$225,045.30</td>
                    </tr>
                    <tr scope="row">
                        <td>17-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-359</td>
                        <td>$645.66</td>
                        <td>-$231,790.22</td>
                    </tr>
                    <tr scope="row">
                        <td>18-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>380</td>
                        <td>$633.82</td>
                        <td>$240,850.84</td>
                    </tr>
                    <tr scope="row">
                        <td>19-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-380</td>
                        <td>$653.82</td>
                        <td>-$248,452.60</td>
                    </tr>
                    <tr scope="row">
                        <td>09-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>514</td>
                        <td>$644.33</td>
                        <td>$331,185.03</td>
                    </tr>
                    <tr scope="row">
                        <td>10-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-514</td>
                        <td>$648.70</td>
                        <td>-$333,430.17</td>
                    </tr>
                    <tr scope="row">
                        <td>20-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>657</td>
                        <td>$639.12</td>
                        <td>$419,904.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-657</td>
                        <td>$645.17</td>
                        <td>-$423,874.43</td>
                    </tr>
                    <tr scope="row">
                        <td>13-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1078</td>
                        <td>$545.61</td>
                        <td>$588,169.54</td>
                    </tr>
                    <tr scope="row">
                        <td>14-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1078</td>
                        <td>$554.09</td>
                        <td>-$597,307.21</td>
                    </tr>
                    <tr scope="row">
                        <td>25-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1208</td>
                        <td>$574.61</td>
                        <td>$694,130.85</td>
                    </tr>
                    <tr scope="row">
                        <td>26-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1208</td>
                        <td>$590.52</td>
                        <td>-$713,345.38</td>
                    </tr>
                    <tr scope="row">
                        <td>27-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1442</td>
                        <td>$587.97</td>
                        <td>$847,859.39</td>
                    </tr>
                    <tr scope="row">
                        <td>28-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1442</td>
                        <td>$623.47</td>
                        <td>-$899,038.77</td>
                    </tr>
                    <tr scope="row">
                        <td>28-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1442</td>
                        <td>$623.47</td>
                        <td>$899,038.77</td>
                    </tr>
                    <tr scope="row">
                        <td>29-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1442</td>
                        <td>$638.18</td>
                        <td>-$920,249.65</td>
                    </tr>
                    <tr scope="row">
                        <td>17-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>2865</td>
                        <td>$640.06</td>
                        <td>$1,833,773.99</td>
                    </tr>
                    <tr scope="row">
                        <td>18-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-2865</td>
                        <td>$646.72</td>
                        <td>-$1,852,859.36</td>
                    </tr>
                    <tr scope="row">
                        <td>07-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>4276</td>
                        <td>$633.34</td>
                        <td>$2,708,158.82</td>
                    </tr>
                    <tr scope="row">
                        <td>08-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-4276</td>
                        <td>$652.24</td>
                        <td>-$2,788,965.41</td>
                    </tr>
                    <tr scope="row">
                        <td>08-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>4276</td>
                        <td>$652.24</td>
                        <td>$2,788,965.41</td>
                    </tr>
                    <tr scope="row">
                        <td>09-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-4276</td>
                        <td>$663.88</td>
                        <td>-$2,838,771.52</td>
                    </tr>
                    <tr scope="row">
                        <td>13-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>4364</td>
                        <td>$658.33</td>
                        <td>$2,872,952.99</td>
                    </tr>
                    <tr scope="row">
                        <td>14-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-4364</td>
                        <td>$669.12</td>
                        <td>-$2,920,040.99</td>
                    </tr>
                    <tr scope="row">
                        <td>21-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>5652</td>
                        <td>$605.14</td>
                        <td>$3,420,235.49</td>
                    </tr>
                    <tr scope="row">
                        <td>22-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-5652</td>
                        <td>$615.78</td>
                        <td>-$3,480,375.96</td>
                    </tr>
                    <tr scope="row">
                        <td>06-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>6928</td>
                        <td>$596.79</td>
                        <td>$4,134,563.08</td>
                    </tr>
                    <tr scope="row">
                        <td>07-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-6928</td>
                        <td>$602.07</td>
                        <td>-$4,171,110.99</td>
                    </tr>
                    <tr scope="row">
                        <td>11-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>6970</td>
                        <td>$624.36</td>
                        <td>$4,351,817.60</td>
                    </tr>
                    <tr scope="row">
                        <td>12-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-6970</td>
                        <td>$629.70</td>
                        <td>-$4,389,003.98</td>
                    </tr>
                    <tr scope="row">
                        <td>26-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>9756</td>
                        <td>$603.58</td>
                        <td>$5,888,541.53</td>
                    </tr>
                    <tr scope="row">
                        <td>27-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-9756</td>
                        <td>$607.04</td>
                        <td>-$5,922,301.08</td>
                    </tr>
                    <tr scope="row">
                        <td>27-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>9756</td>
                        <td>$607.04</td>
                        <td>$5,922,301.08</td>
                    </tr>
                    <tr scope="row">
                        <td>28-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-9756</td>
                        <td>$623.20</td>
                        <td>-$6,079,913.12</td>
                    </tr>
                    <tr scope="row">
                        <td>10-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>12606</td>
                        <td>$616.52</td>
                        <td>$7,771,796.74</td>
                    </tr>
                    <tr scope="row">
                        <td>11-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-12606</td>
                        <td>$636.65</td>
                        <td>-$8,025,610.98</td>
                    </tr>
                    <tr scope="row">
                        <td>22-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>20062</td>
                        <td>$601.23</td>
                        <td>$12,061,836.68</td>
                    </tr>
                    <tr scope="row">
                        <td>23-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-20062</td>
                        <td>$607.30</td>
                        <td>-$12,183,676.84</td>
                    </tr>
                    <tr scope="row">
                        <td>24-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>22064</td>
                        <td>$608.10</td>
                        <td>$13,417,097.66</td>
                    </tr>
                    <tr scope="row">
                        <td>25-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-22064</td>
                        <td>$616.95</td>
                        <td>-$13,612,484.72</td>
                    </tr>
                    <tr scope="row">
                        <td>03-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>27127</td>
                        <td>$609.47</td>
                        <td>$16,532,964.41</td>
                    </tr>
                    <tr scope="row">
                        <td>04-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-27127</td>
                        <td>$618.70</td>
                        <td>-$16,783,466.95</td>
                    </tr>
                    <tr scope="row">
                        <td>09-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>29469</td>
                        <td>$621.71</td>
                        <td>$18,321,214.01</td>
                    </tr>
                    <tr scope="row">
                        <td>10-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-29469</td>
                        <td>$628.62</td>
                        <td>-$18,524,869.19</td>
                    </tr>
                    <tr scope="row">
                        <td>10-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>29469</td>
                        <td>$628.62</td>
                        <td>$18,524,869.19</td>
                    </tr>
                    <tr scope="row">
                        <td>11-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-29469</td>
                        <td>$640.81</td>
                        <td>-$18,883,988.45</td>
                    </tr>
                    <tr scope="row">
                        <td>23-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>38201</td>
                        <td>$667.38</td>
                        <td>$25,494,397.04</td>
                    </tr>
                    <tr scope="row">
                        <td>24-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-38201</td>
                        <td>$677.89</td>
                        <td>-$25,895,927.23</td>
                    </tr>
                    <tr scope="row">
                        <td>05-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>44800</td>
                        <td>$689.56</td>
                        <td>$30,892,457.42</td>
                    </tr>
                    <tr scope="row">
                        <td>06-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-44800</td>
                        <td>$706.41</td>
                        <td>-$31,647,046.48</td>
                    </tr>
                    <tr scope="row">
                        <td>06-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>44800</td>
                        <td>$706.41</td>
                        <td>$31,647,046.48</td>
                    </tr>
                    <tr scope="row">
                        <td>07-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-44800</td>
                        <td>$719.81</td>
                        <td>-$32,247,496.09</td>
                    </tr>
                    <tr scope="row">
                        <td>07-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>44800</td>
                        <td>$719.81</td>
                        <td>$32,247,496.09</td>
                    </tr>
                    <tr scope="row">
                        <td>08-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-44800</td>
                        <td>$736.80</td>
                        <td>-$33,008,787.11</td>
                    </tr>
                    <tr scope="row">
                        <td>12-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>47275</td>
                        <td>$713.82</td>
                        <td>$33,745,687.92</td>
                    </tr>
                    <tr scope="row">
                        <td>13-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-47275</td>
                        <td>$729.87</td>
                        <td>-$34,504,719.44</td>
                    </tr>
                    <tr scope="row">
                        <td>09-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>98167</td>
                        <td>$598.12</td>
                        <td>$58,715,316.02</td>
                    </tr>
                    <tr scope="row">
                        <td>10-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-98167</td>
                        <td>$613.39</td>
                        <td>-$60,215,088.97</td>
                    </tr>
                    <tr scope="row">
                        <td>11-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>100972</td>
                        <td>$611.36</td>
                        <td>$61,730,240.44</td>
                    </tr>
                    <tr scope="row">
                        <td>12-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-100972</td>
                        <td>$632.21</td>
                        <td>-$63,835,756.85</td>
                    </tr>
                    <tr scope="row">
                        <td>16-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>120153</td>
                        <td>$653.20</td>
                        <td>$78,484,461.75</td>
                    </tr>
                    <tr scope="row">
                        <td>17-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-120153</td>
                        <td>$665.72</td>
                        <td>-$79,988,222.31</td>
                    </tr>
                    <tr scope="row">
                        <td>23-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>124232</td>
                        <td>$680.03</td>
                        <td>$84,481,505.76</td>
                    </tr>
                    <tr scope="row">
                        <td>24-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-124232</td>
                        <td>$684.13</td>
                        <td>-$84,990,702.28</td>
                    </tr>
                    <tr scope="row">
                        <td>16-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>444687</td>
                        <td>$555.22</td>
                        <td>$246,896,986.07</td>
                    </tr>
                    <tr scope="row">
                        <td>17-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-444687</td>
                        <td>$579.35</td>
                        <td>-$257,628,751.20</td>
                    </tr>
                    <tr scope="row">
                        <td>22-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>461790</td>
                        <td>$585.22</td>
                        <td>$270,249,801.32</td>
                    </tr>
                    <tr scope="row">
                        <td>23-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-461790</td>
                        <td>$605.72</td>
                        <td>-$279,713,424.11</td>
                    </tr>
                    <tr scope="row">
                        <td>06-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>592609</td>
                        <td>$593.26</td>
                        <td>$351,571,257.30</td>
                    </tr>
                    <tr scope="row">
                        <td>07-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-592609</td>
                        <td>$605.78</td>
                        <td>-$358,987,984.63</td>
                    </tr>
                    <tr scope="row">
                        <td>07-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>592609</td>
                        <td>$605.78</td>
                        <td>$358,987,984.63</td>
                    </tr>
                    <tr scope="row">
                        <td>08-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-592609</td>
                        <td>$619.86</td>
                        <td>-$367,332,580.54</td>
                    </tr>
                    <tr scope="row">
                        <td>14-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>656765</td>
                        <td>$597.21</td>
                        <td>$392,226,078.88</td>
                    </tr>
                    <tr scope="row">
                        <td>15-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-656765</td>
                        <td>$605.87</td>
                        <td>-$397,911,040.57</td>
                    </tr>
                    <tr scope="row">
                        <td>02-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1113907</td>
                        <td>$573.38</td>
                        <td>$638,686,494.11</td>
                    </tr>
                    <tr scope="row">
                        <td>03-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1113907</td>
                        <td>$607.09</td>
                        <td>-$676,243,870.17</td>
                    </tr>
                    <tr scope="row">
                        <td>15-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1734905</td>
                        <td>$641.52</td>
                        <td>$1,112,970,359.63</td>
                    </tr>
                    <tr scope="row">
                        <td>16-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1734905</td>
                        <td>$646.91</td>
                        <td>-$1,122,330,523.66</td>
                    </tr>
                    <tr scope="row">
                        <td>31-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>3117258</td>
                        <td>$579.46</td>
                        <td>$1,806,320,681.30</td>
                    </tr>
                    <tr scope="row">
                        <td>01-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-3117258</td>
                        <td>$598.97</td>
                        <td>-$1,867,157,251.30</td>
                    </tr>
                    <tr scope="row">
                        <td>06-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>3387755</td>
                        <td>$572.39</td>
                        <td>$1,939,109,483.51</td>
                    </tr>
                    <tr scope="row">
                        <td>07-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-3387755</td>
                        <td>$594.80</td>
                        <td>-$2,015,022,365.37</td>
                    </tr>
                    <tr scope="row">
                        <td>07-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>3387755</td>
                        <td>$594.80</td>
                        <td>$2,015,022,365.37</td>
                    </tr>
                    <tr scope="row">
                        <td>08-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-3387755</td>
                        <td>$706.90</td>
                        <td>-$2,394,790,238.47</td>
                    </tr>
                    <tr scope="row">
                        <td>08-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>3387755</td>
                        <td>$706.90</td>
                        <td>$2,394,790,238.47</td>
                    </tr>
                    <tr scope="row">
                        <td>09-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-3387755</td>
                        <td>$722.32</td>
                        <td>-$2,447,054,175.34</td>
                    </tr>
                    <tr scope="row">
                        <td>14-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>3855838</td>
                        <td>$695.70</td>
                        <td>$2,682,494,541.24</td>
                    </tr>
                    <tr scope="row">
                        <td>15-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-3855838</td>
                        <td>$703.90</td>
                        <td>-$2,714,140,465.57</td>
                    </tr>
                    <tr scope="row">
                        <td>15-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>3855838</td>
                        <td>$703.90</td>
                        <td>$2,714,140,465.57</td>
                    </tr>
                    <tr scope="row">
                        <td>16-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-3855838</td>
                        <td>$708.34</td>
                        <td>-$2,731,251,688.06</td>
                    </tr>
                    <tr scope="row">
                        <td>21-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>4229167</td>
                        <td>$682.74</td>
                        <td>$2,887,432,793.91</td>
                    </tr>
                    <tr scope="row">
                        <td>22-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-4229167</td>
                        <td>$686.36</td>
                        <td>-$2,902,742,615.92</td>
                    </tr>
                    <tr scope="row">
                        <td>22-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>4229167</td>
                        <td>$686.36</td>
                        <td>$2,902,742,615.92</td>
                    </tr>
                    <tr scope="row">
                        <td>23-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-4229167</td>
                        <td>$695.41</td>
                        <td>-$2,940,995,359.16</td>
                    </tr>
                    <tr scope="row">
                        <td>26-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>4298390</td>
                        <td>$684.21</td>
                        <td>$2,940,995,482.23</td>
                    </tr>
                    <tr scope="row">
                        <td>27-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-4298390</td>
                        <td>$693.09</td>
                        <td>-$2,979,188,818.18</td>
                    </tr>
                    <tr scope="row">
                        <td>04-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>5606659</td>
                        <td>$737.50</td>
                        <td>$4,134,918,198.77</td>
                    </tr>
                    <tr scope="row">
                        <td>05-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-5606659</td>
                        <td>$743.62</td>
                        <td>-$4,169,248,376.84</td>
                    </tr>
                    <tr scope="row">
                        <td>12-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>6500893</td>
                        <td>$726.05</td>
                        <td>$4,719,992,725.66</td>
                    </tr>
                    <tr scope="row">
                        <td>13-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-6500893</td>
                        <td>$750.49</td>
                        <td>-$4,878,825,762.14</td>
                    </tr>
                    <tr scope="row">
                        <td>20-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>7857863</td>
                        <td>$703.94</td>
                        <td>$5,531,496,233.00</td>
                    </tr>
                    <tr scope="row">
                        <td>21-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-7857863</td>
                        <td>$711.94</td>
                        <td>-$5,594,342,350.79</td>
                    </tr>
                    <tr scope="row">
                        <td>24-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>7610129</td>
                        <td>$735.12</td>
                        <td>$5,594,342,665.30</td>
                    </tr>
                    <tr scope="row">
                        <td>25-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-7610129</td>
                        <td>$745.27</td>
                        <td>-$5,671,600,059.49</td>
                    </tr>
                    <tr scope="row">
                        <td>31-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>10700245</td>
                        <td>$746.69</td>
                        <td>$7,989,722,861.16</td>
                    </tr>
                    <tr scope="row">
                        <td>01-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-10700245</td>
                        <td>$757.82</td>
                        <td>-$8,108,807,496.98</td>
                    </tr>
                    <tr scope="row">
                        <td>15-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>23004069</td>
                        <td>$726.72</td>
                        <td>$16,717,543,026.81</td>
                    </tr>
                    <tr scope="row">
                        <td>16-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-23004069</td>
                        <td>$733.64</td>
                        <td>-$16,876,750,447.96</td>
                    </tr>
                    <tr scope="row">
                        <td>16-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>23004069</td>
                        <td>$733.64</td>
                        <td>$16,876,750,447.96</td>
                    </tr>
                    <tr scope="row">
                        <td>17-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-23004069</td>
                        <td>$737.04</td>
                        <td>-$16,954,978,884.75</td>
                    </tr>
                    <tr scope="row">
                        <td>21-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>23627322</td>
                        <td>$736.94</td>
                        <td>$17,411,986,510.94</td>
                    </tr>
                    <tr scope="row">
                        <td>22-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-23627322</td>
                        <td>$747.16</td>
                        <td>-$17,653,498,870.39</td>
                    </tr>
                    <tr scope="row">
                        <td>06-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>34976545</td>
                        <td>$745.41</td>
                        <td>$26,071,848,390.75</td>
                    </tr>
                    <tr scope="row">
                        <td>07-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-34976545</td>
                        <td>$762.16</td>
                        <td>-$26,657,833,607.43</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>